dihydrotetrabenazine has been researched along with p-chloroamphetamine in 1 studies
Studies (dihydrotetrabenazine) | Trials (dihydrotetrabenazine) | Recent Studies (post-2010) (dihydrotetrabenazine) | Studies (p-chloroamphetamine) | Trials (p-chloroamphetamine) | Recent Studies (post-2010) (p-chloroamphetamine) |
---|---|---|---|---|---|
234 | 4 | 60 | 656 | 0 | 31 |
Protein | Taxonomy | dihydrotetrabenazine (IC50) | p-chloroamphetamine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.207 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.424 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JM; Fleckenstein, AE; Hanson, GR | 1 |
1 other study(ies) available for dihydrotetrabenazine and p-chloroamphetamine
Article | Year |
---|---|
Methamphetamine rapidly decreases vesicular dopamine uptake.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Neurons; Neuropeptides; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Synaptic Vesicles; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |